Erlotinib-induced dermatologic side-effects

被引：9

作者：

Bovenschen, H. Jorn

Alkemade, J. A. C. Hans

机构：

来源：

INTERNATIONAL JOURNAL OF DERMATOLOGY | 2009年 / 48卷 / 03期

关键词：

FACTOR RECEPTOR INHIBITORS; EGF-RECEPTOR; SKIN; MANAGEMENT;

D O I：

10.1111/j.1365-4632.2009.03835.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100227 [皮肤病学];

摘要：

引用

页码：326 / 328

页数：3

共 10 条

[1]

Abell Edward, 1997, P403

[2]

Dermatologic side effects associated with the epidermal growth factor receptor inhibitors [J].

Agero, Anna Liza C. ;

Dusza, Stephen W. ;

Benvenuto-Andrade, Cristiane ;

Busam, Klaus J. ;

Myskowski, Patricia ;

Halpern, Allan C. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 55 (04) :657-670

[3]

Albanell J, 2002, J CLIN ONCOL, V20, P110, DOI 10.1200/JCO.20.1.110

[4]

Gutzmer R, 2006, HAUTARZT, V57, P509, DOI 10.1007/s00105-005-1033-3

[5]

Jost M, 2000, EUR J DERMATOL, V10, P505

[6]

An acneiform eruption due to erlotinib: Prognostic implications and management [J].

Journagan, S ;

Obadiah, J .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (02) :358-360

[7]

Cutaneous side-effects of kinase inhibitors and blocking antibodies [J].

Robert, C ;

Soria, JC ;

Spatz, A ;

Le Cesne, A ;

Malka, D ;

Pautier, P ;

Wechsler, J ;

Lhomme, C ;

Escudier, B ;

Boige, V ;

Armand, JP ;

Le Chevalier, T .

LANCET ONCOLOGY, 2005, 6 (07) :491-500

[8]

Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors [J].

Segaert, S ;

Van Cutsem, E .

ANNALS OF ONCOLOGY, 2005, 16 (09) :1425-1433

[9]

Tjin-A-ton M L R, 2007, Ned Tijdschr Geneeskd, V151, P945

[10]

Erlotinib-associated skin reactions -: case report and proposal for classification [J].

Zoller, A. ;

Schaed, S. G. ;

Gross, G. E. .

BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 (06) :1293-1295

← 1 →